Drugs@FDA document
LEVAQUIN Review · NDA 020635 SUPPL-67
Drugs@FDA document · JANSSEN PHARMS · Mar 11, 2015
Key facts
| Drug name | LEVAQUIN |
|---|---|
| Document type | Review |
| Application | NDA020635 |
| Submission | SUPPL-67 |
| Company | JANSSEN PHARMS |
| Document date | Mar 11, 2015 |
At a glance
- Efficacy-New Indication Document categories
- 100–999 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: